Dysmenorrhea Competitive Landscape Report 2024: R&D Efforts are Limited, with Only Four Drug Candidates Currently in the Pipeline with None in Phase II or Phase III Trials
10 janv. 2025 07h18 HE
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Dysmenorrhea: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the...